相似文献
1
Vaccination with tumor cells pulsed with foreign peptide induces immunity to the tumor itself.
Clin Immunol. 2009 Oct;133(1):45-51. doi: 10.1016/j.clim.2009.06.004. Epub 2009 Jul 9.
2
Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
J Immunol. 2003 Dec 1;171(11):5940-7. doi: 10.4049/jimmunol.171.11.5940.
3
Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
J Immunol. 2006 Feb 1;176(3):1447-55. doi: 10.4049/jimmunol.176.3.1447.
4
New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models.
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-001243.
5
A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival.
Int J Cancer. 2019 Feb 15;144(4):909-921. doi: 10.1002/ijc.31795. Epub 2018 Dec 5.
6
Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanoma.
Cancer Immunol Immunother. 1998 Jan;45(5):217-24. doi: 10.1007/s002620050436.
7
Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Eur J Immunol. 2009 Oct;39(10):2725-36. doi: 10.1002/eji.200939543.
8
Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour.
Clin Exp Immunol. 2010 Oct;162(1):75-83. doi: 10.1111/j.1365-2249.2010.04226.x.
9
In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells.
Cancer Res. 2008 Dec 1;68(23):9892-9. doi: 10.1158/0008-5472.CAN-08-3134.
10
Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2020-000560.
引用本文的文献
1
Functional T Cell Reactivity to Melanocyte Antigens Is Lost during the Progression of Malignant Melanoma, but Is Restored by Immunization.
Cancers (Basel). 2021 Jan 9;13(2):223. doi: 10.3390/cancers13020223.
本文引用的文献
1
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients.
Cancer Res. 2006 Jun 1;66(11):5910-8. doi: 10.1158/0008-5472.CAN-05-3905.
2
Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.
Surgery. 2006 Mar;139(3):407-18. doi: 10.1016/j.surg.2005.06.059.
3
Cross-presentation: underlying mechanisms and role in immune surveillance.
Immunol Rev. 2005 Oct;207:166-83. doi: 10.1111/j.0105-2896.2005.00301.x.
4
New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.
Curr Opin Immunol. 2004 Oct;16(5):550-7. doi: 10.1016/j.coi.2004.07.011.
5
The promise of cancer vaccines.
Nat Rev Cancer. 2004 May;4(5):401-11. doi: 10.1038/nrc1359.
6
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma.
Clin Cancer Res. 2003 Mar;9(3):998-1008.
7
Determinant spreading and tumor responses after peptide-based cancer immunotherapy.
Trends Immunol. 2003 Feb;24(2):58-61. doi: 10.1016/s1471-4906(02)00029-7.
8
Making and breaking tolerance.
Curr Opin Immunol. 2002 Dec;14(6):744-59. doi: 10.1016/s0952-7915(02)00406-5.
9
Antiinfection immunity and autoimmunity.
Ann N Y Acad Sci. 2002 Apr;958:3-6. doi: 10.1111/j.1749-6632.2002.tb02942.x.
10
Checkpoints in the regulation of T helper 1 responses.
Curr Top Microbiol Immunol. 2002;266:23-39. doi: 10.1007/978-3-662-04700-2_3.
Zotero 插件